Consumer Group Urges FDA to Crack Down on Unapproved ‘Abortion Reversal’ Procedure
By Stephanie Russell-Kraft
on June 17, 2020
A consumer watchdog group is asking the U.S. Food and Drug Administration to shut down a group of websites advertising a so-called abortion pill reversal, a potentially dangerous treatment that is not FDA-approved.
One of the sites, called Abortion Pill Rescue, markets what it calls “an effective process called abortion pill reversal that can reverse the effects of the abortion pill.” The site, run by Heartbeat International, a Christian anti-abortion organization, directs visitors to a hotline that can guide them through the procedure. “If you have taken the first dose of the abortion pill and regret it, you are not alone,” the website reads. “We can help you!”
Easy Access to Abortion Pill Vital During Pandemic, FDA Told
June 16, 2020
The FDA should relax restrictions on a medication used for abortion during the pandemic to prevent unnecessary travel, over 100 members of the House said Tuesday in a letter to the agency.
Under the current rules, a person who wants to use mifepristone to help terminate a pregnancy must get it directly from their health-care provider. Mifepristone—which blocks progesterone and stops a pregnancy from advancing—is typically used in combination with a second pill, misoprostol—which causes cramping and bleeding that empties the uterus—when used to terminate a pregnancy. Misoprostol is available at pharmacies with a prescription.
Coronavirus pandemic is fueling efforts to increase access to abortion pills
Marie McCullough - The Philadelphia Inquirer (TNS)
May 29, 2020
The pandemic is helping U.S. abortion-rights advocates achieve a long-standing goal: Make it easier for women to use pills to end pregnancies up to 10 weeks.
Federal and state regulations have restricted access to “medication abortion” ever since the Food and Drug Administration approved it two decades ago. Nonetheless, use of the two-drug regimen has grown steadily, accounting for at least 40% of all abortions, even as the national abortion rate has fallen to historic lows, data show.
New Lawsuit Challenges FDA Restriction That Imposes Life-Threatening Risks on Patients Seeking Abortion and Miscarriage Care
ACLU, leading medical experts and reproductive justice advocates ask court to block FDA restriction that subjects patients and clinicians to needless COVID-19 risk
May 27, 2020
WASHINGTON — The American Civil Liberties Union (ACLU) filed a lawsuit today on behalf of a coalition of medical experts led by the American College of Obstetricians and Gynecologists (ACOG). The legal action challenges a U.S. Food and Drug Administration (FDA) rule that subjects patients to unnecessary COVID-19 risks as a condition of receiving a medication used for early abortion and miscarriage treatment.
ACOG Suit Petitions the FDA to Remove Burdensome Barriers to Reproductive Care During COVID-19
May 27, 2020
Washington, DC – The American College of Obstetricians and Gynecologists (ACOG) took another step toward achieving equitable access to care for patients during the COVID-19 pandemic by asking a federal court to require the U.S. Food and Drug Administration (FDA) to suspend a harmful FDA restriction on mifepristone. Joining ACOG as plaintiffs in today’s lawsuit are the Council of University Chairs of Obstetrics and Gynecology, the New York Academy of Family Physicians, and SisterSong Women of Color Reproductive Justice Collective.
Mifepristone is an evidence-based treatment prescribed for management of early pregnancy loss as well as induced abortion. Although mifepristone has long been proven to be safe and effective when prescribed through telemedicine and can be safely taken in the comfort of a patient’s home, outdated FDA restrictions require mifepristone to be dispensed in a hospital, clinic, or medical office.
Feminist Multi-Front Battle to End FDA’s Abortion Pill Restriction
by Carrie N. Baker
Feminists have been fighting a defensive battle to protect abortion rights for years—but today some are taking the offense, pushing to expand abortion access by calling for the removal of FDA restriction on the abortion pill mifepristone.
Formerly known as RU-486, mifepristone ends pregnancy by blocking the effects of the hormone progesterone, which sustains pregnancy. Used in combination with another drug—misoprostol, which causes contractions to complete an abortion—mifepristone is extremely safe.
Could Coronavirus Make Telemedicine Abortion the New Normal?
Clinics are expanding access with virtual visits and sending pills by mail.
By Anna Louie Sussman
May 19, 2020
Terri first realized she was pregnant in late March. She was isolating at home with her boyfriend in rural upstate New York, where she runs a housecleaning business. At 46, she was sure she didn’t want to become a 60-year-old parent to a teenager. “I was like, ‘No, that’s not going to happen,’” says Terri, who asked to be identified by her first name only. She called the nearest Planned Parenthood clinic, a 40-minute drive away, and took the first appointment available, which was a week-and-a-half later. Uninsured, Terri says she planned to show up at the clinic and “throw [herself] at their mercy.”
But before her appointment, she read about telemedicine abortion. All that was required was a phone consultation with a doctor to establish whether she was less than 10 weeks pregnant (the limit for medication abortion’s approved use by the U.S. Food and Drug Administration). Once proven, the clinic would deliver abortion pills by mail, allowing for a quiet, non-surgical procedure at home. For Terri, this was a far better option than potentially exposing herself to COVID-19 at a clinic.
No-Test Medication Abortion Increases Safety and Access During COVID-19
A new study proposes an innovative, no-test medication abortion protocol that would enable clinicians to safely administer medication abortion to patients without any preliminary tests or in-person encounters
by Carrie N. Baker
Imagine a world where women could access safe and supported abortion health care without ever leaving their homes. In this world, after a phone call or video conference with a health care professional, women could receive the abortion pill in the mail, which they could take safely in the privacy of their own homes under the supervision of a clinician.
No invasive, time-consuming pelvic exams or blood tests. No state-mandated ultrasounds or waiting periods requiring multiple visits. No walking past lines of screaming anti-abortion protesters. No driving long distances, having to find and pay for child care, or taking time off from work. No exposure to COVID-19.
Amid Covid-19, a Call for M.D.s to Mail the Abortion Pill
For decades, the consensus has been that F.D.A. regulations require that the abortion pill be obtained in a clinic. But that’s changing.
By Patrick Adams
May 12, 2020
Last fall, months before America’s first outbreak of the coronavirus, Francine Coeytaux and Elisa Wells, co-founders of the abortion rights advocacy group Plan C, were reaching out to doctors with a question they said was urgent:
“Would you be willing to mail the ‘abortion pills’ to women in their homes?”
Abortion by Telemedicine: A Growing Option as Access to Clinics Wanes
The coronavirus has created a surge in demand for telemedicine of all types — including for a quietly expanding program for terminating pregnancies.
By Pam Belluck
April 28, 2020
Ashley Dale was grateful she could end her pregnancy at home.
As her 3-year-old daughter played nearby, she spoke by video from her living room in Hawaii with Dr. Bliss Kaneshiro, an obstetrician-gynecologist, who was a 200-mile plane ride away in Honolulu. The doctor explained that two medicines that would be mailed to Ms. Dale would halt her pregnancy and cause a miscarriage.